Nickel is now a contrarian play. Does that make it a… smart move?
Despite short term headwinds, Sprott analyst Steve Schoffstall has suggested the time could be right for a contrarian bet on nickel miners Surpluses will peter [more…]
Rise and Shine: Everything you need to know before the ASX opens
Good morning everyone, and welcome to 13 May, 2024 – a curious day in history for a few different reasons. On this day in 942, [more…]
CRITERION: Who’s cashing in on cashing out in India?
Cash here is becoming like the orange-bellied parrot – highly endangered – despite the folding stuff continuing to be the preferred transactional means of many [more…]
Stock Market Stability Amid Federal Rate Challenges
Navigating a Complex Financial Landscape As investors navigate the turbulent waters of the stock market in 2024, the prevailing sentiment on Wall Street is a [more…]
Steve Bannon’s Appeal Loss Deepens Jan. 6 Conviction Saga
In a significant development, the U.S. federal appeals court on Friday affirmed the conviction of Steve Bannon, former chief strategist to ex-President Donald Trump, for [more…]
Luxury travel has changed, man. Here’s what to expect in 2024
Travelling at the pointy end in 2024 is about much more than gold-plated taps and doormen in top hats. Here’s what the big bucks get [more…]
How your sleeping position could be shortening your lifespan
According to experts, your sleeping habits and positions could be causing – or exacerbating – a range of health issues. Here’s what you need to [more…]
The Ethical Investor: After backlash and political meddling, where are we now on ESG investing?
What is ESG investing, and why it matters to investors But ESG investing has received some backlash recently We explain the case for ESG, and [more…]
Barry FitzGerald: South32’s manganese ‘mishap’ is actually ‘like Saudi Arabia going offline for a year’
The ASX-listed manganese stocks are up and about thanks to Cyclone Megan’s arrival at Groote Eylandt on March 16/17. As is usually said when cyclones [more…]
ScoPo’s Powerplays: ASX health stocks rise as Polynovo achieves record $10m revenue month
ASX health stock rise in past five days along with broader markets Wound care company Polynovo achieves its first ever $10m+ revenue month in April [more…]
